Taiwan FDA registration 093cf1d4b6960bf8ee0af6b7ecd71315

"Daishoulin" tumor marker CA15-3 radioimmunoassay reagent

TW: “代首林”腫瘤標記 CA15-3放射免疫分析試劑
Taiwan flagTaiwan·Risk Class 2·DIASORIN INC.;;DIASORIN S.P.A.·Registered Mar 31, 2006 – Mar 31, 2011Cancelled
Registration details
Analysis ID
093cf1d4b6960bf8ee0af6b7ecd71315
Customs Code
DHAS0601627708
Company information
Manufacturer Country
Italy;;United States
Authorized Representative
TAIWAN LIFE SUPPORT SYSTEMS INC.
Product details
Intended Use
Quantitatively measure the amount of CA15-3 antigen (DF3-defining antigen) in human serum.
Product Type (Level 1)
C Immunology and microbiology
Product Type (Level 2)
C.6010 腫瘤相關抗原免疫試驗系統
Import Information
Input;; Consent letter must be attached to the import (consent from the Atomic Energy Commission must be obtained for each import)
Dates and status
Registration Date
Mar 31, 2006
Expiry Date
Mar 31, 2011
Cancellation Date
Nov 27, 2012
Cancellation information
Status
Logged out
Reason
許可證已逾有效期
About this record

Access comprehensive regulatory information for "Daishoulin" tumor marker CA15-3 radioimmunoassay reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 093cf1d4b6960bf8ee0af6b7ecd71315 and manufactured by DIASORIN INC.;;DIASORIN S.P.A.. The authorized representative in Taiwan is TAIWAN LIFE SUPPORT SYSTEMS INC..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free DatabasePowered by Pure Global AI89,000+ Devices